Sickle Cell Disease Trial, Recruiting NCT06770010 Sponsor: Children's National Research Institute Condition: Sickle Cell Disease
Back to Sickle Cell Disease

Sickle Cell Disease Trial, Recruiting

NCT06770010
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with sickle cell disease (any type or form of the condition).
  • Children between the ages of 7 and 16 years old.
  • Children who score low enough on at least one working memory test (a type of memory used to hold and use information in the short term) to show a meaningful weakness in this area — specifically, more than one standard deviation below the average score, or noticeably below what would be expected based on their general intelligence level. This is assessed before entering the treatment part of the trial.

Who may not be able to join:

  • Children who have a physical difficulty with movement, vision, or hearing that would prevent them from using a computer.
  • Children who have been diagnosed with a mental health condition that would either prevent participation in brain-training activities or would need to be treated first before this kind of program could be considered.
  • Children who have a history of seizures triggered by flashing lights or visual patterns (known as photosensitive seizures).
  • Children who do not have enough English language ability to take part in the program.
  • Children who have recently started taking stimulant medication for attention difficulties, or have had their dose changed, within the past 30 days.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Steven Hardy, PhD, Children's National Research Institute

Phone: 202-476-5000

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Children's National Research Institute
Registry
ClinicalTrials.gov
Start date
5 March 2025
Est. completion
1 February 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Number of participants who complete Cogmed training; Number of participants who attend a Cogmed Kickoff social event; Number of participants who participate in memory strategy training

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov